Global Capecitabine Market Research Report 2023(Status and Outlook)

Global Capecitabine Market Research Report 2023(Status and Outlook)



Report Overview

Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.

Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blood cell counts. It is not recommended in people with kidney problems. Use during pregnancy may result in harm to the baby. Capecitabine, inside the body, is converted to 5-fluorouracil (5-FU) through which it acts. It belongs to the class of medications known as fluoropyrimidines, which also includes 5-fluorouracil and tegafur.

Roche, Teva and Mylan are the top 3 of Capecitabine, with about 87% market shares.

The Global Capecitabine Market Size was estimated at USD 1021.80 million in 2022 and is projected to reach USD 993.53 million by 2029, exhibiting a CAGR of -0.40% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Capecitabine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Capecitabine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Capecitabine market in any manner.

Global Capecitabine Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Roche

Teva

Mylan

Hikma

Hengrui Medicine

Cipla

Reliance Group

Hetero

Market Segmentation (by Type)

500 mg

150 mg

Market Segmentation (by Application)

Hot Melt Adhesive

Bitumen Modification

Polymer Modification

Other

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Capecitabine Market

Overview of the regional outlook of the Capecitabine Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Capecitabine
1.2 Key Market Segments
1.2.1 Capecitabine Segment by Type
1.2.2 Capecitabine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Capecitabine Market Overview
2.1 Global Market Overview
2.1.1 Global Capecitabine Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Capecitabine Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Capecitabine Market Competitive Landscape
3.1 Global Capecitabine Sales by Manufacturers (2018-2023)
3.2 Global Capecitabine Revenue Market Share by Manufacturers (2018-2023)
3.3 Capecitabine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Capecitabine Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Capecitabine Sales Sites, Area Served, Product Type
3.6 Capecitabine Market Competitive Situation and Trends
3.6.1 Capecitabine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Capecitabine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Capecitabine Industry Chain Analysis
4.1 Capecitabine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Capecitabine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Capecitabine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Capecitabine Sales Market Share by Type (2018-2023)
6.3 Global Capecitabine Market Size Market Share by Type (2018-2023)
6.4 Global Capecitabine Price by Type (2018-2023)
7 Capecitabine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Capecitabine Market Sales by Application (2018-2023)
7.3 Global Capecitabine Market Size (M USD) by Application (2018-2023)
7.4 Global Capecitabine Sales Growth Rate by Application (2018-2023)
8 Capecitabine Market Segmentation by Region
8.1 Global Capecitabine Sales by Region
8.1.1 Global Capecitabine Sales by Region
8.1.2 Global Capecitabine Sales Market Share by Region
8.2 North America
8.2.1 North America Capecitabine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Capecitabine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Capecitabine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Capecitabine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Capecitabine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Roche
9.1.1 Roche Capecitabine Basic Information
9.1.2 Roche Capecitabine Product Overview
9.1.3 Roche Capecitabine Product Market Performance
9.1.4 Roche Business Overview
9.1.5 Roche Capecitabine SWOT Analysis
9.1.6 Roche Recent Developments
9.2 Teva
9.2.1 Teva Capecitabine Basic Information
9.2.2 Teva Capecitabine Product Overview
9.2.3 Teva Capecitabine Product Market Performance
9.2.4 Teva Business Overview
9.2.5 Teva Capecitabine SWOT Analysis
9.2.6 Teva Recent Developments
9.3 Mylan
9.3.1 Mylan Capecitabine Basic Information
9.3.2 Mylan Capecitabine Product Overview
9.3.3 Mylan Capecitabine Product Market Performance
9.3.4 Mylan Business Overview
9.3.5 Mylan Capecitabine SWOT Analysis
9.3.6 Mylan Recent Developments
9.4 Hikma
9.4.1 Hikma Capecitabine Basic Information
9.4.2 Hikma Capecitabine Product Overview
9.4.3 Hikma Capecitabine Product Market Performance
9.4.4 Hikma Business Overview
9.4.5 Hikma Capecitabine SWOT Analysis
9.4.6 Hikma Recent Developments
9.5 Hengrui Medicine
9.5.1 Hengrui Medicine Capecitabine Basic Information
9.5.2 Hengrui Medicine Capecitabine Product Overview
9.5.3 Hengrui Medicine Capecitabine Product Market Performance
9.5.4 Hengrui Medicine Business Overview
9.5.5 Hengrui Medicine Capecitabine SWOT Analysis
9.5.6 Hengrui Medicine Recent Developments
9.6 Cipla
9.6.1 Cipla Capecitabine Basic Information
9.6.2 Cipla Capecitabine Product Overview
9.6.3 Cipla Capecitabine Product Market Performance
9.6.4 Cipla Business Overview
9.6.5 Cipla Recent Developments
9.7 Reliance Group
9.7.1 Reliance Group Capecitabine Basic Information
9.7.2 Reliance Group Capecitabine Product Overview
9.7.3 Reliance Group Capecitabine Product Market Performance
9.7.4 Reliance Group Business Overview
9.7.5 Reliance Group Recent Developments
9.8 Hetero
9.8.1 Hetero Capecitabine Basic Information
9.8.2 Hetero Capecitabine Product Overview
9.8.3 Hetero Capecitabine Product Market Performance
9.8.4 Hetero Business Overview
9.8.5 Hetero Recent Developments
10 Capecitabine Market Forecast by Region
10.1 Global Capecitabine Market Size Forecast
10.2 Global Capecitabine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Capecitabine Market Size Forecast by Country
10.2.3 Asia Pacific Capecitabine Market Size Forecast by Region
10.2.4 South America Capecitabine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Capecitabine by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Capecitabine Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Capecitabine by Type (2024-2029)
11.1.2 Global Capecitabine Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Capecitabine by Type (2024-2029)
11.2 Global Capecitabine Market Forecast by Application (2024-2029)
11.2.1 Global Capecitabine Sales (K MT) Forecast by Application
11.2.2 Global Capecitabine Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings